Independent Oversight for Outsourced Clinical Trials
Helping sponsors see how their trials are actually run, identify risks and strengthen oversight.
Helping sponsors see how their trials are actually run, identify risks and strengthen oversight.
Sponsors increasingly outsource clinical trial operations to CROs and specialized vendors. Monitoring teams, operational reports, and governance meetings help keep sponsors informed about study progress and key activities.
However, these mechanisms are primarily designed to manage day-to-day operations rather than give sponsors a comprehensive view of how critical aspects of trial execution are performing across sites, vendors, and processes.
As a result, sponsors may assume that trials are operating smoothly while operational risks, inconsistent monitoring practices, or oversight gaps develop beneath the surface.
Silvertree BioLife provides independent oversight reviews that give sponsors a clearer understanding of how their trials are actually being executed.
Rather than relying solely on operational reporting, these reviews examine key elements of trial execution across monitoring activities, site performance, vendor oversight, and protocol deviation management.
This independent perspective helps sponsors identify emerging risks earlier, confirm that oversight mechanisms are functioning effectively, and strengthen governance of CRO-managed trials.

Silvertree supports sponsors through independent trial oversight reviews, CRO governance frameworks, and targeted quality audits.
Structured independent reviews that provide sponsors with a clearer view of how an ongoing trial is actually being executed.
These reviews examine critical elements of trial conduct including monitoring practices, vendor oversight, protocol deviation management, site performance, and emerging operational risk signals.
Many biotech companies outsource clinical trials but lack a clear framework for overseeing CRO performance and governance.
Silvertree helps sponsors strengthen CRO oversight through governance frameworks, monitoring quality assessments, escalation processes, performance reviews, and oversight dashboards.
Think of this as independent sponsor-side oversight of CRO-managed operations.
Traditional quality audits remain an essential tool for verifying trial execution.
Silvertree conducts independent audits of sites, vendors, processes, and TMF health to confirm that trial activities are being conducted in accordance with regulatory expectations and sponsor oversight responsibilities.
These audits provide objective verification of trial execution quality.

Silvertree BioLife works with sponsors navigating the operational complexity of outsourced clinical trials.
Our work is particularly valuable for organizations that rely on CROs and external vendors to execute their studies but want stronger visibility into how trials are actually being conducted.
Organizations running outsourced clinical trials that require independent oversight and governance support without building large internal quality teams.
Companies seeking clearer visibility into monitoring quality, vendor performance, and overall trial execution across outsourced partners.
Trials approaching regulatory inspection, partnership diligence, or critical development milestones where oversight assurance becomes essential.
Organizations looking to improve CRO governance structures, escalation pathways, and oversight processes across their clinical programs.
As programs scale and CRO execution expands, sponsor oversight must remain structured, visible, and accountable.
Silvertree helps you ensure it does.
Silvertree BioLife
SPONSOR OVERSIGHT | CLINICAL TRIAL GOVERNANCE